(Q38132055)

29 August 2017

title

Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature (English)

1 reference

29 August 2017

1 reference

angiogenesis inhibitor

1 reference

Shujing Shi

1

1 reference

29 August 2017

Longbang Chen

series ordinal

2

1 reference

29 August 2017

Guichun Huang

series ordinal

3

1 reference

29 August 2017

publication date

28 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

30

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

698

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-013-0698-1

29 August 2017

exact match

0 references

cites work

CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Therapeutic targeting of tumor-stroma interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

2011: the immune hallmarks of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Pathology: cancer cells compress intratumour vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Hypoxia promotes tumor growth in linking angiogenesis to immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Dendritic-cell control of pathogen-driven T-cell polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Dendritic cell regulation of TH1-TH2 development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Adenosine receptors in regulation of dendritic cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Molecular pathways: hypoxia response in immune cells fighting or promoting cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Normalization of the vasculature for treatment of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Discrepancies between antiangiogenic and antitumor effects of recombinant human endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Overcoming obstacles to the effective immunotherapy of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0698-1

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia

21 January 2018

1 reference

12 December 2020

Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study

1 reference

12 December 2020

Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas

1 reference

12 December 2020

Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.

1 reference

12 December 2020

Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma

1 reference

12 December 2020

Effects of hypoxia on interleukin-2 mRNA expression by T lymphocytes

1 reference

12 December 2020

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer

1 reference

12 December 2020

Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models

1 reference

12 December 2020

10.1007/S12032-013-0698-1

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1001623145

0 references

1 reference